Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Beta 3 Agonist Treatment in Heart Failure

NCT01876433 is registered in ClinicalTrials.gov with Henning Bundgaard as lead sponsor.

NCT NCT01876433
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01876433 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Beta 3 Agonist Treatment in Heart Failure
Lead sponsor
Henning Bundgaard
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2013
Completion date
September 30, 2015
Enrollment
70 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chronic heart failure with reduced ejection fraction (hfref)